CRANBURY, N.J.--(BUSINESS WIRE)--Physicians’ Education Resource® (PER®), the leading resource for oncology and hematology continuing medical education (CME), will host the 17th Annual International Congress on the Future of Breast Cancer® West on July 13-14 at The Westin San Diego Gaslamp Quarter in California.
The program will be co-chaired by Sara Hurvitz, M.D., director, breast cancer clinical research program, co-director, Santa Monica – University of California Los Angeles (UCLA) outpatient hematology/ oncology practice, associate professor of medicine, division of hematology/ oncology, David Geffen School of Medicine at UCLA and Joyce O’Shaughnessy, M.D., Celebrating Women Chair in Breast Cancer Research, Baylor Charles A. Sammons Cancer Center, Texas Oncology and co-chair, breast cancer research program, The U.S. Oncology Network.
“The treatment of breast cancer has experienced tremendous growth and advances,” said Phil Talamo, president of PER®. “Together with Dr. Hurvitz and Dr. O’Shaughnessy, we look forward to discussing the emerging data and the value of personalized treatments to optimize patient care.”
Designed for medical, surgical and radiation oncologists, the 17th Annual International Congress on the Future of Breast Cancer®® presents the latest treatment advances for breast cancer. The meeting will discuss the appropriate use and interpretation of biomarker results and molecular or genomic assays in individualized treatment. Attendees will have an opportunity to engage with international leaders in breast cancer treatment. This year’s conference will also discuss the use of immunotherapy for patients with advanced breast cancer and will delve into neoadjuvant endocrine therapy.
For registration and more information, visit http://www.gotoper.com/conferences/ibc/meetings/17th-annual-international-congress-on-the-future-of-breast-cancer.
About PER®
Since 1995, Physicians’ Education Resource, LLC® (PER®) has been the leading provider of live and online continuing medical education activities on oncology and hematology by providing high-quality, evidence-based activities featuring leading experts who focus on the application of practice-changing advances. In 2018, PER® will develop and implement 20 historic annual legacy conferences in the United States and Europe, along with many world-renowned online learning formats such as Medical Crossfire®. PER® is accredited by both the Accreditation Council for Continuing Medical Education and the California Board of Registered Nursing. PER® is part of the Cranbury, New Jersey-based MJH Associates, Inc. family of businesses. Learn more at gotoper.com and mjhassoc.com.
